Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORA | P35398 | 2/20 | 0.37 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | RORB | Q92753 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25682734 | 0.94 | RORA (0.42) | RORARORCRORBSIGMAR1KDM4E | |
| SCHEMBL25684320 | 0.93 | HPGD (0.40) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL25684442 | 0.92 | UTS2R (0.38) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL25684445 | 0.89 | HPGD (0.39) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL19652601 | 0.86 | GPR3 (0.40) | RORCKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL25683783 | 0.85 | RORA (0.38) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL25683515 | 0.84 | KDM4E (0.38) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL13183674 | 0.82 | GPR3 (0.48) | KDM4EALDH1A1HPGDHSD17B10MAPT | |
| SCHEMBL25683586 | 0.81 | RORA (0.40) | RORARORCRORBSIGMAR1ADRA2A | |
| SCHEMBL25998067 | 0.81 | RORA (0.40) | RORARORCRORBSIGMAR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | RORA 630/4885RORC 1177/4885RORB 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.